46.46.Z - Wholesale of pharmaceutical goods
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
46.45.Z - Wholesale of perfume and cosmetics
47.29.Z - Other retail sale of food in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 0,6 | 0,5 | -14,2 |
EBITDA | 1 | 1,5 | 1,4 | -6,8 |
Short time liabilities | 11,9 | 13,1 | 10,9 | -16,9 |
Equity capital | 4,6 | 4,4 | 4,8 | 7 |
Operating profit (EBIT) | 0,6 | 0,9 | 0,9 | 1,2 |
Assets | 16,8 | 17,5 | 19 | 8,5 |
Net profit (loss) | 0,3 | 0,4 | 0,3 | -24,2 |
Cash | 0,1 | 0,1 | 0 | -70,3 |
Net income from sale | 21,6 | 24,8 | 26,4 | 6,2 |
Liabilities and provisions for liabilities | 12,2 | 13,1 | 14,3 | 9 |
Working assets | 12,9 | 15,5 | 17,3 | 12,2 |
Depreciation | 0,4 | 0,6 | 0,5 | -18,7 |
% | % | % | p.p. | |
Profitability of capital | 7,6 | 9,3 | 6,6 | -2,7 |
Equity capital to total assets | 27,5 | 25,4 | 25 | -0,4 |
Gross profit margin | 2,3 | 2,3 | 1,9 | -0,4 |
EBITDA Margin | 4,6 | 5,9 | 5,2 | -0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 202 | 192 | 150 | -42 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane